Viewing Study NCT01069861


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2025-12-27 @ 10:46 PM
Study NCT ID: NCT01069861
Status: TERMINATED
Last Update Posted: 2021-02-01
First Post: 2010-02-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-12
Start Date Type: None
Primary Completion Date: 2011-11
Primary Completion Date Type: ACTUAL
Completion Date: 2011-11
Completion Date Type: ACTUAL
First Submit Date: 2010-02-15
First Submit QC Date: None
Study First Post Date: 2010-02-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2012-11-01
Results First Submit QC Date: None
Results First Post Date: 2012-12-03
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-01-28
Last Update Post Date: 2021-02-01
Last Update Post Date Type: ACTUAL